Primary Record
Alfathesin
Note: Only for scientific research or as raw materials for production.
- In stock
- 1,504 g
- Purity
- 99.0 %
- CAS
- 8067-82-1
Compound Identifiers & Properties
- CAS
- 8067-82-1
- PubChem CID
- 24732
- SMILES
- CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@H](C4)O)C)C.CC(=O)OCC(=O)[C@H]1CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@H](C4)O)C)C
- Canonical SMILES
- CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C.CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C
Names & Synonyms
- Alfathesin
- Saffan
- Alphadione
- Alfadione
- Alfatesine
- Aurantex
- Alphathesin
- ALTHESIN
- Glaxovet
- Alfatesine [French]
- alfaxolone/alfadolone
- AC1L2NMV
- RefChem:388780
- Alfaxalone Alfadolone Mixture
- Alfadolone Mixture, Alfaxalone
- CT-1341
- DTXSID001001405
- SCHEMBL29722811
- YYPNLXNMXQFMHG-GSEHKNNPSA-N
- Alfaxalone mixture with alfadolone acetate
- CID24732
- 8067-82-1
- CID:24732
- CT1341
- C23H34O5.C21H32O3
- CT 1341
- C23H34O5.3C21H32O3
- SID:134224776
- LS-118549
- C23-H34-O5.C21-H32-O3
- D000530
- Q4721889
- (3R,5S,8S,9S,10S,13S,14S,17S)-17-acetyl-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-one;[2-[(3R,5S,8S,9S,10S,13S,14S,17S)-3-hydroxy-10,13-dimethyl-11-oxo-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
- Pregnane-11,20-dione, 21-(acetyloxy)-3-hydroxy-, (3alpha,5alpha)-, mixt. with (3alpha,5alpha)-3-hydroxypregnane-11,20-dione
- 5-alpha-Pregnane-11,20-dione, 3-alpha-hydroxy- mixed with 3-alpha,21-dihydroxy-5-alpha-pregnane-11,20-dione 21-acetate (3:1)
- 3-Hydroxy-11,20-dioxopregnan-21-yl acetate--3-hydroxypregnane-11,20-dione (1/1)
- (3|A,5|A)-3-Hydroxy-11,20-dioxopregnan-21-yl acetate - (3|A,5|A)-3-hy droxypregnane-11,20-dione (1:1)
- (3R,5S,8S,9S,10S,13R,14S,17S)-17-acetyl-3-hydroxy-10,13-dimethyl-1,2,3 ,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11- one: [2-[(3R,5S,8S,9S,10S,13R,14S,17S)-3-hydroxy-10,13-dimethyl-11-oxo -1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetrade
- (3R,5S,8S,9S,10S,13R,14S,17S)-17-acetyl-3-hydroxy-10,13-dimethyl-1,2,3 ,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11- one: [2-[(3R,5S,8S,9S,10S,13R,14S,17S)-3-hydroxy-10,13-dimethyl-11-oxo -1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradec
- (3R,5S,8S,9S,10S,13R,14S,17S)-17-Acetyl-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-one:[2-[(3R,5S,8S,9S,10S,13R,14S,17S)-3-hydroxy-10,13-dim
- (3R,5S,8S,9S,10S,13S,14S,17S)-17-acetyl-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-one; [2-[(3R,5S,8S,9S,10S,13S,14S,17S)-3-hydroxy-10,13-dimethyl-11-oxo-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
- 3alpha-Hydroxy-11,20-dioxo-5alpha-pregnan-21-yl acetate--3alpha-hydroxy-5alpha-pregnane-11,20-dione (1/1)
- Pregnane-11,20-dione, 21-(acetyloxy)-3-hydroxy-, (3.alpha.,5.alpha.)-, mixt. with (3.alpha.,5.alpha.)-3-hydroxypregnane-11,20-dione